Retained Earnings (Accumulated Deficit) in USD of Mereo BioPharma Group plc from Q4 2022 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Mereo BioPharma Group plc quarterly Retained Earnings (Accumulated Deficit) history and change rate from Q4 2022 to Q3 2025.
  • Mereo BioPharma Group plc Retained Earnings (Accumulated Deficit) for the quarter ending 30 Sep 2025 was -$494M, a 8.3% decline year-over-year.
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Mereo BioPharma Group plc Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 -$494M -$37.8M -8.3% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 -$487M -$45.8M -10.4% 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$472M -$43.4M -10.1% 31 Mar 2025 10-Q 13 May 2025
Q4 2024 -$463M -$43.3M -10.3% 31 Dec 2024 10-Q 10 Nov 2025
Q3 2024 -$456M 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 -$441M 30 Jun 2024 10-Q 13 Aug 2024
Q1 2024 -$429M 31 Mar 2024 10-Q 15 May 2024
Q4 2023 -$420M -$15.1M -3.72% 31 Dec 2023 10-K 26 Mar 2025
Q4 2022 -$405M 31 Dec 2022 10-K 27 Mar 2024
* An asterisk sign (*) next to the value indicates that the value is likely invalid.